PMC:7195088 / 20028-20272 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"668","span":{"begin":93,"end":101},"obj":"Species"},{"id":"789","span":{"begin":14,"end":24},"obj":"Chemical"},{"id":"790","span":{"begin":42,"end":61},"obj":"Chemical"},{"id":"932","span":{"begin":126,"end":134},"obj":"Disease"},{"id":"933","span":{"begin":214,"end":223},"obj":"Disease"}],"attributes":[{"id":"A668","pred":"tao:has_database_id","subj":"668","obj":"Tax:9606"},{"id":"A789","pred":"tao:has_database_id","subj":"789","obj":"MESH:D003078"},{"id":"A790","pred":"tao:has_database_id","subj":"790","obj":"MESH:C558899"},{"id":"A932","pred":"tao:has_database_id","subj":"932","obj":"MESH:C000657245"},{"id":"A933","pred":"tao:has_database_id","subj":"933","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Comparison of colchicine (with or without lopinavir/ritonavir) vs. local standard of care in patients with moderate to severe COVID-19. Open-label RCT (NCT04328480, not yet recruiting). Primary endpoint: all-cause mortality (follow-up 30 days)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T98","span":{"begin":126,"end":134},"obj":"Disease"}],"attributes":[{"id":"A98","pred":"mondo_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Comparison of colchicine (with or without lopinavir/ritonavir) vs. local standard of care in patients with moderate to severe COVID-19. Open-label RCT (NCT04328480, not yet recruiting). Primary endpoint: all-cause mortality (follow-up 30 days)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T102","span":{"begin":141,"end":146},"obj":"http://purl.obolibrary.org/obo/CLO_0007225"}],"text":"Comparison of colchicine (with or without lopinavir/ritonavir) vs. local standard of care in patients with moderate to severe COVID-19. Open-label RCT (NCT04328480, not yet recruiting). Primary endpoint: all-cause mortality (follow-up 30 days)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T203","span":{"begin":14,"end":24},"obj":"Chemical"},{"id":"T204","span":{"begin":42,"end":61},"obj":"Chemical"},{"id":"T205","span":{"begin":42,"end":51},"obj":"Chemical"},{"id":"T206","span":{"begin":52,"end":61},"obj":"Chemical"},{"id":"T207","span":{"begin":141,"end":146},"obj":"Chemical"}],"attributes":[{"id":"A203","pred":"chebi_id","subj":"T203","obj":"http://purl.obolibrary.org/obo/CHEBI_23359"},{"id":"A204","pred":"chebi_id","subj":"T204","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A205","pred":"chebi_id","subj":"T205","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A206","pred":"chebi_id","subj":"T206","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A207","pred":"chebi_id","subj":"T207","obj":"http://purl.obolibrary.org/obo/CHEBI_35209"}],"text":"Comparison of colchicine (with or without lopinavir/ritonavir) vs. local standard of care in patients with moderate to severe COVID-19. Open-label RCT (NCT04328480, not yet recruiting). Primary endpoint: all-cause mortality (follow-up 30 days)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T139","span":{"begin":136,"end":185},"obj":"Sentence"},{"id":"T140","span":{"begin":186,"end":244},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Comparison of colchicine (with or without lopinavir/ritonavir) vs. local standard of care in patients with moderate to severe COVID-19. Open-label RCT (NCT04328480, not yet recruiting). Primary endpoint: all-cause mortality (follow-up 30 days)."}